Strategy
MSTR
MARA Holdings
MARA
Petroleo Brasileiro SA Petrobras
PBR
4
Adobe
ADBE
5
Vale SA
VALE
US Stock MarketDetailed Quotes
PTGX Protagonist Therapeutics
- 54.780
- -0.120-0.22%
Close Mar 14 16:00 ET
- 54.780
- 0.0000.00%
Post 20:01 ET
3.36BMarket Cap12.95P/E (TTM)
55.390High53.530Low1.27MVolume55.000Open54.900Pre Close69.32MTurnover2.58%Turnover Ratio12.95P/E (Static)61.38MShares60.60052wk High4.98P/B2.70BFloat Cap24.22052wk Low--Dividend TTM49.26MShs Float60.600Historical High--Div YieldTTM3.39%Amplitude4.470Historical Low54.515Avg Price1Lot Size
Protagonist Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Mar 14, 2025
The average Protagonist Therapeutics stock price target is 71.80 with a max estimate of 82.00 and a min estimate of 65.00
Review Protagonist Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025